Keloid Treatment Market
Market Insights on Keloid Treatment covering sales outlook, demand forecast & up-to-date key trends
Keloid Treatment Market By Treatment types (Occlusive Dressing, Compression Therapy, Cryosurgery, Excision, Radiation Therapy, Laser Therapy, Interferon Therapy, Intralesional Corticosteroid Injection), End users (Hospitals, Dermatology Clinics, Ambulatory Surgical Centres) & Region - Forecast to 2017 - 2027
Market introduction and factors influencing market revenue growth
Keloid is an overgrowth of the scar tissues that develop from a wound. Keloid development usually happens after the wound has healed. Keloids grow beyond the border of a scar and develop into a lump. The cause of keloid development cannot be determined but it can develop after surgery, burn injury, piercing, trauma, acne, vaccination and other wounds or cuts. According to the National Institute of Health, keloid scars are commonly seen in people in the age group 10 to 30 years of age.
Keloid scars are also more commonly found in people of African American, Asian, or Hispanic descent. Increasing consciousness among people for their looks and appearance (keloids on the exposed part of the body give an ugly look and need treatment to remove or reduce the keloid size) is expected to drive the market for keloid treatment.
The demand for keloid treatment is expected to surge owing to the increasing incidence of the scars, the shift from monotherapy to combination therapy and increasing adoption of advanced cryosurgery and radiation therapy devices.
A growing focus on reimbursement of various advanced keloid therapies is also expected to drive revenue growth of the global market. There is a noticeable increase in the adoption of advanced treatment options that can reduce the rate of recurrence of keloid scars and remove such scars completely.
Also, combinations therapies are also used to improve the effectiveness of treatment and restrict the recurrence rate. However, complications pertaining to keloid treatment and higher recurrence rate post treatment are some of the factors expected to restrain revenue growth of the global keloid treatment market.
Let us know your requirement to get
100% FREE customization
Intralesional corticosteroid injections to remain most favoured treatment type for keloid scars
Of the various treatment types currently administered in the global keloid treatment market, intralesional corticosteroid injections followed by excisions are likely to remain a favourite among physicians and patients. Intralesional corticosteroid injections are considered the standard treatment option and is given in combination with other therapies to reduce the recurrence rate of keloid scars.
Intralesional corticosteroid injections is the largest segment by treatment type in the global keloid treatment market, which is estimated to represent US$ 906.0 Mn, or 28.8% share of the total market in 2017 and is projected to reach a market valuation of US$ 1,200.1 Mn, or 27.2% share of the total market by the end of the forecast period in 2027, expanding at a CAGR of 2.9% in terms of value.
Excision treatment type segment is anticipated to reach a market value of US$ 1,172.1 Mn by 2027 end, expanding at a CAGR of 3.4% during the forecast period. Radiation therapy keloid treatment type segment is estimated to represent a market attractiveness index of 1.8 during the forecast period.
The global keloid treatment market offers several opportunities to key players
Development of innovative therapies: Prevention and treatment of keloids is a challenge for the medical field. Management of keloid and hypotrophic scars has transitioned from invasive therapies, including surgical excision to topical and intralesional therapies. There is no standard treatment available for the management of keloid scars and usually, a combination of therapies is performed. There is limited evidence data available for the proper management of keloid and hypotrophic scars.
However, continuous research on keloid treatment has made it possible to develop innovative therapy options for treatment. Superficial radiation therapy provides non-invasive treatment for keloid and hypotrophic scars.
The global keloid treatment market is highly underpenetrated: Keloids affect a large portion of the population, especially those having undergone surgery, trauma, burn injuries and other such conditions. There is limited impact of keloid scars on patient health and only a small portion of the patient population undertakes treatment options in keloid cases. Also, there is limited reimbursement for keloid treatment and the available treatment options are not effective for complete removal or treatment of keloid.
Owning to these factors, the global keloid treatment market is highly underpenetrated. Effective treatment therapies with limited side effects and lowered risk of keloid recurrence can provide a very lucrative opportunity for companies operating in the global keloid treatment market.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystMarket segmentation
The global keloid treatment market is segmented as follows:
- Keloid treatment market, by treatment type
- Keloid treatment market, by end user
- Keloid treatment market, by region
The keloid treatment market report begins with an overview of keloid treatment and key market definitions. This section also underlines factors influencing revenue growth of the global keloid treatment market along with a detailing of the key trends, drivers, restraints, and opportunities. The next section of the report analyses the market based on treatment type and presents the forecast in terms of value for the next 10 years. Treatment types covered in the report include:
- Occlusive Dressing
- Compression Therapy
- Cryosurgery
- Excision
- Radiation Therapy
- Laser Therapy
- Interferon Therapy
- Intralesional Corticosteroid Injection
- Others
The subsequent section covers the market analysis based on end user and presents the forecast in terms of value for the next 10 years. End users considered in the report include:
- Hospitals
- Dermatology Clinics
- Ambulatory Surgical Centres
- Others
The next section of the report highlights the growth trends of the keloid treatment market across various regions, providing a market outlook for 2017–2027 and setting the forecast within the context of the keloid treatment market. The study discusses key regional trends contributing to the growth of the keloid treatment market worldwide, as well as analyses the extent to which drivers are influencing this market in each region. Key regions assessed in this report include North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East & Africa.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Frequently Asked Questions
The keloid treatment market size is anticipated to be over US$ 7.7 Bn in 2022.
Asia Pacific is likely to witness the highest growth in the keloid treatment market.
The keloid treatment market size is expected to be US$ 17.9 Bn by 2032.
The keloid treatment market is likely to record a CAGR of 8.75% through 2032.
Table of Content
1. Executive Summary
1.1. Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
3. Keloid Treatment Market View Point Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
3.3. Epidemiology Analysis
3.4. Risk Factor Distribution
3.5. Recurrence Rate Analysis
3.6. Patient Population Distribution
4. North America Keloid Treatment Market Analysis 2012–2016 and Forecast 2017–2027
4.1. Market Snapshot
4.2. Introduction
4.3. Regional Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Trends
4.4. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
4.4.1. U.S.
4.4.2. Canada
4.5. Market Size (US$ Mn) Forecast By Country, 2017–2027
4.5.1. U.S.
4.5.2. Canada
4.6. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2012–2016
4.6.1. Occlusive Dressing
4.6.2. Compression Therapy
4.6.3. Cryosurgery
4.6.4. Excision
4.6.5. Radiation Therapy
4.6.6. Laser Therapy
4.6.7. Interferon Therapy
4.6.8. Intralesional Corticosteroid Injection
4.6.9. Others
4.7. Market Size (US$ Mn) and Volume Forecast By Treatment Type, 2017–2027
4.7.1. Occlusive Dressing
4.7.2. Compression Therapy
4.7.3. Cryosurgery
4.7.4. Excision
4.7.5. Radiation Therapy
4.7.6. Laser Therapy
4.7.7. Interferon Therapy
4.7.8. Intralesional Corticosteroid Injection
4.7.9. Others
4.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
4.8.1. Hospitals
4.8.2. Dermatology Clinics
4.8.3. Ambulatory Surgical Centers
4.8.4. Other
4.9. Market Size (US$ Mn) Forecast By End User, 2017–2027
4.9.1. Hospitals
4.9.2. Dermatology Clinics
4.9.3. Ambulatory Surgical Centers
4.9.4. Other
4.10. Market Attractiveness Analysis
4.10.1. By Country
4.10.2. By Treatment Type
4.10.3. By End User
5. Latin America Keloid Treatment Market Analysis 2012–2016 and Forecast 2017–2027
5.1. Market Snapshot
5.2. Introduction
5.3. Regional Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Trends
5.4. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
5.4.1. Brazil
5.4.2. Mexico
5.4.3. Rest of Latin America
5.5. Market Size (US$ Mn) Forecast By Country, 2017–2027
5.5.1. Brazil
5.5.2. Mexico
5.5.3. Rest of Latin America
5.6. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2012–2016
5.6.1. Occlusive Dressing
5.6.2. Compression Therapy
5.6.3. Cryosurgery
5.6.4. Excision
5.6.5. Radiation Therapy
5.6.6. Laser Therapy
5.6.7. Interferon Therapy
5.6.8. Intralesional Corticosteroid Injection
5.6.9. Others
5.7. Market Size (US$ Mn) and Volume Forecast By Treatment Type, 2017–2027
5.7.1. Occlusive Dressing
5.7.2. Compression Therapy
5.7.3. Cryosurgery
5.7.4. Excision
5.7.5. Radiation Therapy
5.7.6. Laser Therapy
5.7.7. Interferon Therapy
5.7.8. Intralesional Corticosteroid Injection
5.7.9. Others
5.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
5.8.1. Hospitals
5.8.2. Dermatology Clinics
5.8.3. Ambulatory Surgical Centers
5.8.4. Other
5.9. Market Size (US$ Mn) Forecast By End User, 2017–2027
5.9.1. Hospitals
5.9.2. Dermatology Clinics
5.9.3. Ambulatory Surgical Centers
5.9.4. Other
5.10. Market Attractiveness Analysis
5.10.1. By Country
5.10.2. By Treatment Type
5.10.3. By End User
6. Western Europe Keloid Treatment Market Analysis 2012–2016 and Forecast 2017–2027
6.1. Market Snapshot
6.2. Introduction
6.3. Regional Market Dynamics
6.3.1. Drivers
6.3.2. Restraints
6.3.3. Trends
6.4. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
6.4.1. Germany
6.4.2. Italy
6.4.3. France
6.4.4. Spain
6.4.5. U.K.
6.4.6. Rest of Western Europe
6.5. Market Size (US$ Mn) Forecast By Country, 2017–2027
6.5.1. Germany
6.5.2. Italy
6.5.3. France
6.5.4. Spain
6.5.5. U.K.
6.5.6. Rest of Western Europe
6.6. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2012–2016
6.6.1. Occlusive Dressing
6.6.2. Compression Therapy
6.6.3. Cryosurgery
6.6.4. Excision
6.6.5. Radiation Therapy
6.6.6. Laser Therapy
6.6.7. Interferon Therapy
6.6.8. Intralesional Corticosteroid Injection
6.6.9. Others
6.7. Market Size (US$ Mn) and Volume Forecast By Treatment Type, 2017–2027
6.7.1. Occlusive Dressing
6.7.2. Compression Therapy
6.7.3. Cryosurgery
6.7.4. Excision
6.7.5. Radiation Therapy
6.7.6. Laser Therapy
6.7.7. Interferon Therapy
6.7.8. Intralesional Corticosteroid Injection
6.7.9. Others
6.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
6.8.1. Hospitals
6.8.2. Dermatology Clinics
6.8.3. Ambulatory Surgical Centers
6.8.4. Other
6.9. Market Size (US$ Mn) Forecast By End User, 2017–2027
6.9.1. Hospitals
6.9.2. Dermatology Clinics
6.9.3. Ambulatory Surgical Centers
6.9.4. Other
6.10. Market Attractiveness Analysis
6.10.1. By Country
6.10.2. By Treatment Type
6.10.3. By End User
7. Eastern Europe Keloid Treatment Market Analysis 2012–2016 and Forecast 2017–2027
7.1. Market Snapshot
7.2. Introduction
7.3. Regional Market Dynamics
7.3.1. Drivers
7.3.2. Restraints
7.3.3. Trends
7.4. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
7.4.1. Russia
7.4.2. Poland
7.4.3. Rest of Eastern Europe
7.5. Market Size (US$ Mn) Forecast By Country, 2017–2027
7.5.1. Russia
7.5.2. Poland
7.5.3. Rest of Eastern Europe
7.6. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2012–2016
7.6.1. Occlusive Dressing
7.6.2. Compression Therapy
7.6.3. Cryosurgery
7.6.4. Excision
7.6.5. Radiation Therapy
7.6.6. Laser Therapy
7.6.7. Interferon Therapy
7.6.8. Intralesional Corticosteroid Injection
7.6.9. Others
7.7. Market Size (US$ Mn) and Volume Forecast By Treatment Type, 2017–2027
7.7.1. Occlusive Dressing
7.7.2. Compression Therapy
7.7.3. Cryosurgery
7.7.4. Excision
7.7.5. Radiation Therapy
7.7.6. Laser Therapy
7.7.7. Interferon Therapy
7.7.8. Intralesional Corticosteroid Injection
7.7.9. Others
7.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
7.8.1. Hospitals
7.8.2. Dermatology Clinics
7.8.3. Ambulatory Surgical Centers
7.8.4. Other
7.9. Market Size (US$ Mn) Forecast By End User, 2017–2027
7.9.1. Hospitals
7.9.2. Dermatology Clinics
7.9.3. Ambulatory Surgical Centers
7.9.4. Other
7.10. Market Attractiveness Analysis
7.10.1. By Country
7.10.2. By Treatment Type
7.10.3. By End User
8. Asia Pacific excluding Japan Keloid Treatment Market Analysis 2012–2016 and Forecast 2017–2027
8.1. Market Snapshot
8.2. Introduction
8.3. Regional Market Dynamics
8.3.1. Drivers
8.3.2. Restraints
8.3.3. Trends
8.4. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
8.4.1. China
8.4.2. India
8.4.3. Australia and New Zealand
8.4.4. Rest of APEJ
8.5. Market Size (US$ Mn) Forecast By Country, 2017–2027
8.5.1. China
8.5.2. India
8.5.3. Australia and New Zealand
8.5.4. Rest of APEJ
8.6. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2012–2016
8.6.1. Occlusive Dressing
8.6.2. Compression Therapy
8.6.3. Cryosurgery
8.6.4. Excision
8.6.5. Radiation Therapy
8.6.6. Laser Therapy
8.6.7. Interferon Therapy
8.6.8. Intralesional Corticosteroid Injection
8.6.9. Others
8.7. Market Size (US$ Mn) and Volume Forecast By Treatment Type, 2017–2027
8.7.1. Occlusive Dressing
8.7.2. Compression Therapy
8.7.3. Cryosurgery
8.7.4. Excision
8.7.5. Radiation Therapy
8.7.6. Laser Therapy
8.7.7. Interferon Therapy
8.7.8. Intralesional Corticosteroid Injection
8.7.9. Others
8.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
8.8.1. Hospitals
8.8.2. Dermatology Clinics
8.8.3. Ambulatory Surgical Centers
8.8.4. Other
8.9. Market Size (US$ Mn) Forecast By End User, 2017–2027
8.9.1. Hospitals
8.9.2. Dermatology Clinics
8.9.3. Ambulatory Surgical Centers
8.9.4. Other
8.10. Market Attractiveness Analysis
8.10.1. By Country
8.10.2. By Treatment Type
8.10.3. By End User
9. Japan Keloid Treatment Market Analysis 2012–2016 and Forecast 2017–2027
9.1. Market Snapshot
9.2. Introduction
9.3. Regional Market Dynamics
9.3.1. Drivers
9.3.2. Restraints
9.3.3. Trends
9.4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2012–2016
9.4.1. Occlusive Dressing
9.4.2. Compression Therapy
9.4.3. Cryosurgery
9.4.4. Excision
9.4.5. Radiation Therapy
9.4.6. Laser Therapy
9.4.7. Interferon Therapy
9.4.8. Intralesional Corticosteroid Injection
9.4.9. Others
9.5. Market Size (US$ Mn) and Volume Forecast By Treatment Type, 2017–2027
9.5.1. Occlusive Dressing
9.5.2. Compression Therapy
9.5.3. Cryosurgery
9.5.4. Excision
9.5.5. Radiation Therapy
9.5.6. Laser Therapy
9.5.7. Interferon Therapy
9.5.8. Intralesional Corticosteroid Injection
9.5.9. Others
9.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
9.6.1. Hospitals
9.6.2. Dermatology Clinics
9.6.3. Ambulatory Surgical Centers
9.6.4. Other
9.7. Market Size (US$ Mn) Forecast By End User, 2017–2027
9.7.1. Hospitals
9.7.2. Dermatology Clinics
9.7.3. Ambulatory Surgical Centers
9.7.4. Other
9.8. Market Attractiveness Analysis
9.8.1. By Treatment Type
9.8.2. By End User
10. Middle East & Africa Keloid Treatment Market Analysis 2012–2016 and Forecast 2017–2027
10.1. Market Snapshot
10.2. Introduction
10.3. Regional Market Dynamics
10.3.1. Drivers
10.3.2. Restraints
10.3.3. Trends
10.4. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
10.4.1. GCC Countries
10.4.2. South Africa
10.4.3. Rest of MEA
10.5. Market Size (US$ Mn) Forecast By Country, 2017–2027
10.5.1. GCC Countries
10.5.2. South Africa
10.5.3. Rest of MEA
10.6. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2012–2016
10.6.1. Occlusive Dressing
10.6.2. Compression Therapy
10.6.3. Cryosurgery
10.6.4. Excision
10.6.5. Radiation Therapy
10.6.6. Laser Therapy
10.6.7. Interferon Therapy
10.6.8. Intralesional Corticosteroid Injection
10.6.9. Others
10.7. Market Size (US$ Mn) and Volume Forecast By Treatment Type, 2017–2027
10.7.1. Occlusive Dressing
10.7.2. Compression Therapy
10.7.3. Cryosurgery
10.7.4. Excision
10.7.5. Radiation Therapy
10.7.6. Laser Therapy
10.7.7. Interferon Therapy
10.7.8. Intralesional Corticosteroid Injection
10.7.9. Others
10.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
10.8.1. Hospitals
10.8.2. Dermatology Clinics
10.8.3. Ambulatory Surgical Centers
10.8.4. Other
10.9. Market Size (US$ Mn) Forecast By End User, 2017–2027
10.9.1. Hospitals
10.9.2. Dermatology Clinics
10.9.3. Ambulatory Surgical Centers
10.9.4. Other
10.10. Market Attractiveness Analysis
10.10.1. By Country
10.10.2. By Treatment Type
10.10.3. By End User
11. Competition Landscape
11.1. Competition Dashboard
11.2. Company Profiles (Details – Overview, Financials, Strategy, SWOT)
11.2.1. Novartis AG
11.2.2. Sensus Healthcare
11.2.3. RXi Pharmaceuticals, Inc.
11.2.4. Sonoma Pharmaceuticals, Inc.
11.2.5. Perrigo Company plc.
11.2.6. Bristol-Myers Squibb Company
11.2.7. Pacific World Corporation
11.2.8. Valeant Pharmaceutical International, Inc.
11.2.9. Revitol Corporation
11.2.10. Avita Medical Limited
12. Global Keloid Treatment Market Analysis 2012–2016 and Forecast 2017–2027, By Region
12.1. Introduction/Key Findings
12.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2012–2016
12.2.1. North America
12.2.2. Latin America
12.2.3. Western Europe
12.2.4. Eastern Europe
12.2.5. Asia Pacific excluding Japan
12.2.6. Japan
12.2.7. Middle East & Africa
12.3. Market Size (US$ Mn) Forecast By Region, 2017–2027
12.3.1. North America
12.3.2. Latin America
12.3.3. Western Europe
12.3.4. Eastern Europe
12.3.5. Asia Pacific excluding Japan
12.3.6. Japan
12.3.7. Middle East & Africa
12.4. Market Attractiveness Analysis By Region
13. Global Pain Therapeutic Solutions Market Analysis 2012–2016 and Forecast 2017–2027, By Treatment Type
13.1. Introduction/Key Findings
13.2. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2012–2016
13.2.1. Occlusive Dressing
13.2.2. Compression Therapy
13.2.3. Cryosurgery
13.2.4. Excision
13.2.5. Radiation Therapy
13.2.6. Laser Therapy
13.2.7. Interferon Therapy
13.2.8. Intralesional Corticosteroid Injection
13.2.9. Others
13.3. Market Size (US$ Mn) Forecast By Treatment Type, 2017–2027
13.3.1. Occlusive Dressing
13.3.2. Compression Therapy
13.3.3. Cryosurgery
13.3.4. Excision
13.3.5. Radiation Therapy
13.3.6. Laser Therapy
13.3.7. Interferon Therapy
13.3.8. Intralesional Corticosteroid Injection
13.3.9. Others
13.4. Market Attractiveness Analysis By Treatment Type
14. Global Keloid Treatment Market Analysis 2012–2016 and Forecast 2017–2027, By End User
14.1. Introduction/Key Findings
14.2. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
14.2.1. Hospitals
14.2.2. Dermatology Clinics
14.2.3. Ambulatory Surgical Centers
14.2.4. Others
14.3. Market Size (US$ Mn) Forecast By End User, 2017–2027
14.3.1. Hospitals
14.3.2. Dermatology Clinics
14.3.3. Ambulatory Surgical Centers
14.3.4. Others
14.4. Market Attractiveness Analysis By End User
15. Global Keloid Treatment Market Analysis 2012–2016 and Forecast 2017–2027
15.1. Market Size and Y-o-Y Growth
15.2. Absolute $ Opportunity
16. Acronyms Used
17. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: North America Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 02: North America Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Treatment Type
Table 03: North America Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By End User
Table 04: Latin America Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 05: Latin America Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Treatment Type
Table 06: Latin America Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By End User
Table 07: Western Europe Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 08: Western Europe Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Treatment Type
Table 09: Western Europe Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By End User
Table 10: Eastern Europe Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 11: Eastern Europe Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Treatment Type
Table 12: Eastern Europe Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By End User
Table 13: APEJ Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 14: APEJ Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Treatment Type
Table 15: APEJ Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By End User
Table 16: Japan Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By End User
Table 17: Japan Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Region
Table 18: MEA Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 19: MEA Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Treatment Type
Table 20: MEA Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By End User
Table 21: Global Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Region
Table 22: Global Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Treatment Type
Table 23: Global Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By End User
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Keloid Treatment Market Value Share By Treatment Type (2016)
Figure 2: Keloid Treatment Market Value Share By End User (2016)
Figure 3: Keloid Treatment Market Value Share By Region (2016)
Figure 4: North America Keloid Treatment Market Value Share By Treatment Type (2017)
Figure 5: North America Keloid Treatment Market Value Share By End User (2017)
Figure 6: North America Keloid Treatment Market Value Share By Region (2017)
Figure 07: North America Keloid Treatment Market Size Analysis, 2012-2016
Figure 08: North America Keloid Treatment Market Forecast, 2017–2027
Figure 10: U.S. Keloid Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 12: Canada Keloid Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 09: U.S. Keloid Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 11: Canada Keloid Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 13: North America Keloid Treatment Market Attractiveness Analysis, By Treatment Type, 2017–2027
Figure 14: North America Keloid Treatment Market Attractiveness Analysis, End User, 2017–2027
Figure 15: North America Keloid Treatment Market Attractiveness Analysis, By Region, 2017–2027
Figure 16: Latin America Keloid Treatment Market Value Share By Treatment Type (2017)
Figure 17: Latin America Keloid Treatment Market Value Share By End User (2017)
Figure 18: Latin America Keloid Treatment Market Value Share By Region (2017)
Figure 19: Latin America Keloid Treatment Market Size Analysis, 2012-2016
Figure 20: Latin America Keloid Treatment Market Forecast, 2017–2027
Figure 22: Brazil Keloid Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 24: Mexico Keloid Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 21: Brazil Keloid Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 23: Mexico Keloid Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 25: Rest of Latin America Keloid Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 27: Latin America Keloid Treatment Market Attractiveness Analysis, By Treatment Type, 2017–2027
Figure 28: Latin America Keloid Treatment Market Attractiveness Analysis, End User, 2017–2027
Figure 29: Latin America Keloid Treatment Market Attractiveness Analysis, By Region, 2017–2027
Figure 30: Western Europe Keloid Treatment Market Value Share By Treatment Type (2017)
Figure 31: Western Europe Keloid Treatment Market Value Share By End User (2017)
Figure 32: Western Europe Keloid Treatment Market Value Share By Region (2017)
Figure 33: Western Europe Keloid Treatment Market Size Analysis, 2012-2016
Figure 34: Western Europe Keloid Treatment Market Forecast, 2017–2027
Figure 36: Germany Keloid Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 38: France Keloid Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 35: Germany Keloid Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 37: France Keloid Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 40: U.K. Keloid Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 42: Italy Keloid Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 39: U.K. Keloid Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 41: Italy Keloid Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 44: Spain Keloid Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 46: Rest of WE Keloid Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 43: Spain Keloid Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 45: Rest of WE Keloid Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 47: Western Europe Keloid Treatment Market Attractiveness Analysis, By Treatment Type, 2017–2027
Figure 48: Western Europe Keloid Treatment Market Attractiveness Analysis, End User, 2017–2027
Figure 49: Western Europe Keloid Treatment Market Attractiveness Analysis, By Region, 2017–2027
Figure 50: Eastern Europe Keloid Treatment Market Value Share By Treatment Type (2017)
Figure 51: Eastern Europe Keloid Treatment Market Value Share By End User (2017)
Figure 52: Eastern Europe Keloid Treatment Market Value Share By Region (2017)
Figure 53: Eastern Europe Keloid Treatment Market Size Analysis, 2012-2016
Figure 54: Eastern Europe Keloid Treatment Market Forecast, 2017–2027
Figure 56: Russia Keloid Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 58: Poland Keloid Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 55: Russia Keloid Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 57: Poland Keloid Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 61: Eastern Europe Keloid Treatment Market Attractiveness Analysis, By Treatment Type, 2017–2027
Figure 62: Eastern Europe Keloid Treatment Market Attractiveness Analysis, End User, 2017–2027
Figure 63: Eastern Europe Keloid Treatment Market Attractiveness Analysis, By Region, 2017–2027
Figure 64: APEJ Keloid Treatment Market Value Share By Treatment Type (2017)
Figure 65: APEJ Keloid Treatment Market Value Share By End User (2017)
Figure 66: APEJ Keloid Treatment Market Value Share By Region (2017)
Figure 67: APEJ Keloid Treatment Market Size Analysis, 2012-2016
Figure 68: APEJ Keloid Treatment Market Forecast, 2017–2027
Figure 70: China Keloid Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 72: India Keloid Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 69: China Keloid Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 71: India Keloid Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 74: A&NZ Keloid Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 76: Rest of APEJ Keloid Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 73: A&NZ Keloid Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 75: Rest of APEJ Keloid Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 77: APEJ Keloid Treatment Market Attractiveness Analysis, By Treatment Type, 2017–2027
Figure 78: APEJ Keloid Treatment Market Attractiveness Analysis, End User, 2017–2027
Figure 79: APEJ Keloid Treatment Market Attractiveness Analysis, By Region, 2017–2027
Figure 80: APEJ Keloid Treatment Market Value Share By Treatment Type (2017)
Figure 81: APEJ Keloid Treatment Market Value Share By End User (2017)
Figure 82: Japan Keloid Treatment Market Size Analysis, 2012-2016
Figure 83: Japan Keloid Treatment Market Forecast, 2017–2027
Figure 84: Japan Keloid Treatment Market Attractiveness Analysis, By Treatment Type, 2017–2027
Figure 85: Japan Keloid Treatment Market Attractiveness Analysis, End User, 2017–2027
Figure 86: MEA Keloid Treatment Market Value Share By Treatment Type (2017)
Figure 87: MEA Keloid Treatment Market Value Share By End User (2017)
Figure 88: MEA Keloid Treatment Market Value Share By Region (2017)
Figure 89: MEA Keloid Treatment Market Size Analysis, 2012-2016
Figure 90: MEA Keloid Treatment Market Forecast, 2017–2027
Figure 92: GCC Countries Keloid Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 94: South Africa Keloid Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 91: GCC Countries Keloid Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 93: South Africa Keloid Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 97: MEA Keloid Treatment Market Attractiveness Analysis, By Treatment Type, 2017–2027
Figure 98: MEA Keloid Treatment Market Attractiveness Analysis, End User, 2017–2027
Figure 99: MEA Keloid Treatment Market Attractiveness Analysis, By Region, 2017–2027
Figure 100: Global Keloid Treatment Market Y-o-Y Growth (%) Analysis 2017-2027, By Region
Figures highlight market Y-o-Y growth rate for Keloid Treatment by region over 2017–2027
Figure 101: Global Keloid Treatment Market Y-o-Y Growth (%) Analysis 2017-2027, By Region
Figure highlights global keloid treatment market attractiveness analysis by region for 2017–2027
Figure 102: Global Keloid Treatment Market Y-o-Y Growth (%) Analysis 2017-2027, By Treatment Type
Figures highlight market Y-o-Y growth rate for keloid treatment market by treatment type over 2017–2027
Figure 103: Global Keloid Treatment Market Y-o-Y Growth (%) Analysis 2017-2027, By Treatment Type
Figure highlights global Keloid Treatment market attractiveness analysis by treatment type for 2017–2027
Figure 104: Global Keloid Treatment Market Y-o-Y Growth (%) Analysis 2017-2027, By End User
Figures highlight market Y-o-Y growth rate for keloid treatment by End User over 2017–2027
Figure 105: Global Keloid Treatment Market Y-o-Y Growth (%) Analysis 2017-2027, By End User
Figure highlights global keloid treatment market attractiveness analysis by End User for 2017–2027
Figure 106: Global Keloid Treatment Market Value Analysis and Forecast, 2016–2027 (US$ Mn)
Figure 107: Global Keloid Treatment Market Value (US$ Mn), 2012–2016
Figure 108: Global Keloid Treatment Market Absolute $ Opportunity (US$ Mn), 2016–2027
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
